Press Releases

Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility

TOURS, France, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced that it has secured a EUR 5.7 million grant under...

Clinical Trials Market to Reach USD 112.9 Bn by 2035, Expanding at a CAGR of 5.2% | Transparency Market Research

Clinical Trials Market expanding steadily with increasing focus on precision medicine and global drug development WILMINGTON, DE, UNITED STATES, September 29, 2025 /⁨EINPresswire.com⁩/ -- The global clinical trials market is poised for sustained...

[Latest] Global Direct Reduced Iron Market Size/Share Worth USD 96.4 Billion by 2034 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Direct Reduced Iron Market Size, Trends and Insights By Product Type (Hot Briquetted Iron, Cold Direct Reduced Iron), By...

Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations

Press Release Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations Additional pre-planned analysis of the NCX 470 Denali trial completed NCX 470 maintains robust intraocular...

Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight

New York, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight According to DelveInsight’s analysis, the market for Lyme disease is anticipated to...

Ophthalmic Disease Therapeutics Market Size, Share, Trends, Key Players, Competitor Insights & Regional Report 2025-2032

Ophthalmic Disease Therapeutics Market revenue is expected to grow at a CAGR of 8.9% from 2025 to 2032, reaching nearly USD 74.7 Bn. WILMINGTON, DE, UNITED STATES, October 1, 2025 /⁨EINPresswire.com⁩/ -- Ophthalmic Disease Therapeutics Market set...

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Pr. Yann Gouëffic and affiliates (FRANCE-PAD) cover ~8% of all CLTI cases in France BERKELEY, Calif, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering...

Europe Pharmaceutical CDMO Market Size Expected to Reach USD 70.05 Billion by 2034

Ottawa, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Europe pharmaceutical CDMO market size was valued at USD 35.48 billion in 2024 and is predicted to hit around USD 70.05 billion by 2034, rising at a 7.04% CAGR, a study published by Towards Healthcare...

Liver Health Supplements Market Outlook : Projected to Exceed USD 3.11 Billion by 2032 with a 12.8 % CAGR | Coherent Market Insights

Burlingame, CA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global Liver Health Supplements Market is estimated to be valued at USD 1.34 Bn in 2025 and is expected to reach USD 3.11 Bn by 2032, exhibiting a...

Global Hospital Capacity Management Solutions Market Size/Share Worth USD 9.3 Billion by 2034 at a 10.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hospital Capacity Management Solutions Market Size, Trends and Insights By Solution Type (Capacity Management Software, Capacity...

Global Epoxy Resins Market to Hit USD 18.52 billion by 2034, Driven by Growing Demand in Automotive, and Transportation

Get insights into the world epoxy resins market, fueled by automotive, transportation, and construction demand, with major trends, uses, and drivers of growth. NEW YORK CITY, NY, UNITED STATES, October 7, 2025 /⁨EINPresswire.com⁩/ -- 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗘𝗽𝗼𝘅𝘆...

RNAi Therapeutics Market to Hit $8.8B by 2033, Driven by Rare & Cardiovascular Diseases & siRNA and Delivery Innovations

RNAi Therapeutics Market forecast: $8.8 Billion by 2033. Key growth from siRNA, GalNAc delivery tech, North America leadership, APAC fastest rise. AUSTIN, TX, UNITED STATES, October 1, 2025 /⁨EINPresswire.com⁩/ -- According to DataM Intelligence,...

Atrial Fibrillation Clinical Trials & Pipeline Overview: Insights into 12+ Leading Companies and 15+ Novel Treatments | DelveInsight

New York, USA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Atrial Fibrillation Clinical Trials & Pipeline Overview: Insights into 12+ Leading Companies and 15+ Novel Treatments | DelveInsight Atrial Fibrillation, the most common cardiac arrhythmia, poses...

Phoenix Homes Brings Dubai’s Largest Private Residence to Market in Al Barari

Phoenix Homes brings Dubai’s largest private residence currently on the market, with a plot of 56,000 square feet with 38,000 square feet of built-up area. DUBAI, UNITED ARAB EMIRATES, October 7, 2025 /⁨EINPresswire.com⁩/ -- Phoenix Homes has...

Global Healthcare Analytical Testing Services Market to Grow at a CAGR of 10% During the Forecast Period (2025–2030): Wissen Research

Sheridan, Sept. 30, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global healthcare analytical testing services market was valued at USD 11.2 billion in 2024. Furthermore, the market is expected...

Your Doctors Online (YDO) Rises as One of Canada’s Top Telemedicine Platform Amid Healthcare Strain

Ontario families face long waits—Your Doctors Online offers Canada’s top telemedicine platform with instant care and online prescriptions TORONTO, ONTARIO, CANADA, September 30, 2025 /⁨EINPresswire.com⁩/ -- Recent headlines in Ontario have...

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial

Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease Patients” Significant improvement in...

Rare Disease Treatment Market Size to Worth USD 587.08 Billion by 2034

Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global rare disease treatment market size was valued at USD 195.21 billion in 2024 and is predicted to hit around USD 587.08 billion by 2034, rising at a 11.64% CAGR, a study published by Towards...

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...

Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight

New York, USA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional...